National Benchmarking Study

National Benchmarking Study of Pharmacogenetic Testing for Warfarin

Authors: E. J. Stanek, C. L. Sanders, G. Hawk, F. W. Frueh, M. Pacanowsi, I. Zineh, L. Lesko, R. S. Epstein

In 2007, 1.58/100 of new warfarin users had a Pgx test, with younger patients more likely to be tested. In 2008, the testing rate was 1.71/100. We report a national benchmark of warfarin PGx testing and anticipate that this number may increase as additional clinical outcome studies are completed.

Citation: Clin Pharmacol Ther 87: S39-S65; doi:10.1038/clpt.2009.274

Link: http://www.nature.com/clpt/journal/v87/n1s/pdf/clpt2009274a.pdf